Citation

Tribble DR, Ganesan A, Rodriguez CJ. Curr Fungal Infect Rep 2020; 14(2): 186-196.

Copyright

(Copyright © 2020)

DOI

10.1007/s12281-020-00385-4

PMID

32665807 PMCID

Abstract

PURPOSE of review: This review highlights research from the past five years on combat trauma-related invasive fungal wound infections (IFIs) with a focus on risk stratification to aid patient management, microbiology, and diagnostics.

Recent Findings: A revised classification scheme stratifies wounds into three risk groups: IFI, High Suspicion of IFI, and Low Suspicion of IFI. This stratification is based on persistence of wound necrosis and laboratory fungal evidence, presence of signs/symptoms of deep soft-tissue infections, and the need for antifungals. Use of this classification could allow for prioritization of antifungal therapy. Further, IFIs delay wound healing, particularly when caused by fungi of the order Mucorales. Lastly, molecular sequencing offers promising and complimentary results to the gold standard histopathology.

Summary: Optimal management of combat-related IFIs depends on early tissue-based diagnosis with aggressive surgical debridement and concomitant dual antifungal therapy. Further research on clinical decision support tools and rapid diagnostics are needed.

Language: en

Keywords

combat-related; invasive fungal infections; mucormycosis; trauma-related; wound infections